Legend Biotech Corporation, a global biotechnology company that develops, manufactures and commercializes novel therapies to treat life-threatening diseases, announced the filing of a Application...
Plexision, a biotechnology company, which provides personalized diagnostic testing services for organ transplant patients has completed development of a six-hour blood test to predict...
Arthrosi Therapeutics, Inc., a clinical-stage biotechnology company, announced the completion of enrollment for its global Phase 2b clinical study of AR882 for the treatment...
Orna Therapeutics, a biotechnology company pioneering a new class of fully engineered circular RNA therapies (oRNA), announced the initial closing of its $221 million...
Inhibrx, Inc., a biotechnology company with four clinical programs in development and a strong emerging pipeline, announced that the European Commission ("EC"), based on...
